An Observational Study of the Risk of Malignant Neoplasms and Malignant Neoplasms of Special Interest (Thyroid and Pancreatic Cancer) in Subjects Treated with Albiglutide Compared to Those Treated with Other Antidiabetic Agents (201805) First published 15/12/2015 Last updated 14/08/2020 EU PAS number:EUPAS11850 Study Finalised